Modulation of cellular proliferation and induction of apoptosis in a human lymphoma cell line after treatment with selective lipoxygenase inhibitors.
Anderson
K M
KM
Dept. of Medical Oncology, Rush Medical College, Chicago, IL 60612, USA.
Ondrey
F G
FG
Harris
J E
JE
D058927:5-Lipoxygenase-Activating Proteins; D000081:Acetamides / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects*; D001094:Arachidonate 5-Lipoxygenase / Q000235:genetics; D002352:Carrier Proteins / Q000037:antagonists & inhibitors / Q000235:genetics; D002455:Cell Division / Q000187:drug effects*; D003470:Culture Media; D006801:Humans; D007211:Indoles / Q000494:pharmacology; D016859:Lipoxygenase Inhibitors / Q000494:pharmacology*; D009637:Masoprocol / Q000494:pharmacology; D008565:Membrane Proteins / Q000037:antagonists & inhibitors / Q000235:genetics; D010647:Phenyl Ethers; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D020298:U937 Cells; D002722:Chlorobenzenes
D058927:5-Lipoxygenase-Activating Proteins; D000081:Acetamides; D001094:Arachidonate 5-Lipoxygenase; D002352:Carrier Proteins; D003470:Culture Media; D007211:Indoles; D016859:Lipoxygenase Inhibitors; D009637:Masoprocol; D008565:Membrane Proteins; D010647:Phenyl Ethers; D012333:RNA, Messenger; C548592:ALOX5AP protein, human; C068663:N-hydroxy-N-(1-(4-(phenylmethoxy)phenyl)ethyl)-acetamide; C060893:MK-886; D002722:Chlorobenzenes